- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jose P. Leone Highlights the Importance of Breast Cancer Awareness for Male Patients
Jose P. Leone, MD, director of the program for breast cancer in men at the Dana-Farber Cancer Institute and assistant professor of medicine at Harvard Medical School, shares why patients and providers need to pay more attention to how breast cancer impacts male patients.
More patients and providers need to be aware that breast cancer can happen in men in order to improve treatment and survival rates in this population, according to Jose P. Leone, MD, director of the program for breast cancer in men at the Dana-Farber Cancer Institute and assistant professor of medicine at Harvard Medical School.
Transcript
How has the diagnosis and treatment of men with breast cancer evolved over time, and what more needs to be done to ensure adequate treatment for this population?
Leone: So, breast cancer treatment in men has historically mirrored the treatment for women. And many of those things are actually still being done today. So, for example, the use of tamoxifen as a standard endocrine therapy option in men remains the current standard today. The use of mastectomy initially, and then, the adoption of other possible surgical options, such as lumpectomy in men, has been something that has changed over time also. We look forward to having more data in some of the questions that we have in clinics to move the field forward in the treatment of breast cancer in men and to get data specific for men as compared with women.
What are some of the challenges that are unique to treating men with breast cancer?
Leone: One of the biggest challenges is the lack of data specific for men. Sometimes there are no studies done to answer a particular question. Sometimes the studies are of lower quality than the size that we're used to seeing in women. And that, to me, is one of the biggest challenges in in managing this type of breast cancer.
What do you wish that more oncologists and health care professionals understood about breast cancer in male patients?
Leone: One of the main things for me, personally, I think, is awareness and to be aware that breast cancer can happen in men because early diagnosis of men who present with signs and symptoms of breast cancer is very important given the lack of screening mammograms in this population. So, I would like people to be aware that this can happen and not delay to the workups, which sometimes happens.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Evaluating Label Warnings, Switching Rates in Patients With Psoriasis Initiating New Treatment
November 9th 2023Posters presented at the 2023 Fall Clinical Dermatology Conference evaluated how label warnings may affect new treatment initiation and real-word switching patterns for patients starting risankizumab.
Read More
Innovation in Value-Based Care Requires More Data, Patient-Centered Thinking
November 9th 2023In a panel discussion at the 2023 Patient-Centered Oncology Care® meeting held in Nashville, Tennessee, experts discussed the Enhancing Oncology Model and themes in the movement toward value-based care in oncology.
Read More
